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Abstract
Background: Childhood obesity is a public health problem worldwide. Visceral obesity, particularly associated with
cardio-metabolic risk, has been assessed by body mass index (BMI) and waist circumference, but both methods use
sex-and age-specific percentile tables and are influenced by sexual maturity. Waist-to-height ratio (WHtR) is easier to
obtain, does not involve tables and can be used to diagnose visceral obesity, even in normal-weight individuals.
This study aims to compare the WHtR to the 2007 World Health Organization (WHO) reference for BMI in screening
for the presence of cardio-metabolic and inflammatory risk factors in 6–10-year-old children.
Methods: A cross-sectional study was undertaken with 175 subjects selected from the Reference Center for the
Treatment of Children and Adolescents in Campos, Rio de Janeiro, Brazil. The subjects were classified according to
the 2007 WHO standard as normal-weight (BMI z score > −1 and < 1) or overweight/obese (BMI z score ≥ 1).
Systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting glycemia, low-density lipoprotein (LDL), high-
density lipoprotein (HDL), triglyceride (TG), Homeostatic Model Assessment – Insulin Resistance (HOMA-IR),
leukocyte count and ultrasensitive C-reactive protein (CRP) were also analyzed.
Results: There were significant correlations between WHtR and BMI z score (r = 0.88, p < 0.0001), SBP (r = 0.51,
p < 0.0001), DBP (r = 0.49, p < 0.0001), LDL (r = 0.25, p < 0.0008, HDL (r = −0.28, p < 0.0002), TG (r = 0.26, p <
0.0006), HOMA-IR (r = 0.83, p < 0.0001) and CRP (r = 0.51, p < 0.0001). WHtR and BMI areas under the curve were
similar for all the cardio-metabolic parameters. A WHtR cut-off value of > 0.47 was sensitive for screening insulin
resistance and any one of the cardio-metabolic parameters.
Conclusions: The WHtR was as sensitive as the 2007 WHO BMI in screening for metabolic risk factors in 6-10-year-old
children. The public health message “keep your waist to less than half your height” can be effective in reducing cardio-
metabolic risk because most of these risk factors are already present at a cut point of WHtR ≥ 0.5. However, as this is
the first study to correlate the WHtR with inflammatory markers, we recommend further exploration of the use of
WHtR in this age group and other population-based samples.
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Background
Obesity is subclinical inflammation characterized by the
secretion of cytokines that influence the formation of
atherosclerotic plaque and endothelial dysfunction [1].
This inflammatory process begins in childhood and in-
volves leukocytes and the hepatic secretion of C-reactive
protein (CRP), whose serum levels are significantly
correlated with abdominal adiposity in adolescents [2].
Although the relationship between abdominal obesity and
cardio-metabolic disorders has already been demonstrated
through the assessment of the abdominal circumference
in adults, in children there are controversies. For some au-
thors [3] body mass index (BMI) and waist circumference
(WC) are equal indicators of metabolic risk, whereas
others believe WC to be a better indicator [4]. Because
both WC and BMI depend on the use of sex- and age-
specific percentile tables in children, waist-to-height ratio
(WHtR) has emerged as new option that is more attractive
than these other anthropometric indices. WHtR is easier
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to obtain, does not require reference tables, is less
influenced by sexual maturity, is suitable for population
and epidemiologic studies and can be used on a large
scale in screening for metabolic risk in both adults and
children [5,6].
The objective of this study is to compare the WHtR to
the 2007 World Health Organization (WHO) reference
for BMI in screening for the presence of cardio- meta-
bolic and inflammatory risk factors in normal-weight
and overweight/obese 6–10-year-old children.
Methods
This was a cross-sectional study of a sequential sample
of children from the Pediatric Endocrinology outpatient
clinic of the Reference Center for the Treatment of Chil-
dren and Adolescents (CRTCA) in Campos, State of Rio
de Janeiro, in the southeast of Brazil. Data were collected
between November 2006 and April 2008. The sample
comprised 175 children of both sexes aged 6–10. All sub-
jects were classified as Tanner staging as pre-adolescents,
with no apparent secondary sexual characteristic. Most
participants were from low-income families and many
were of African American descent. Although puberty may
start earlier in African Americans, it was not seen in our
cohort. About 60% of the children were referred to the
CRTCA by pediatricians or brought by their own parents
who were worried about their health. The remaining 40%
were sent by the principals of public schools in Campos,
after personal contact to explain the aim of the study. The
reason for sending children who were slim was to check
whether their weight or height was normal. Overweight/
obese children were sent for this reason or because
dyslipidemia had been found on initial screening by a
pediatrician. Children with thyroid, kidney or liver disor-
ders, psychiatric diseases, non-essential hypertension or
acute or chronic infections, who were using any medica-
tion that could interfere with the variables analyzed, or
who were undergoing treatment for weight control were
excluded. According to these criteria three children were
excluded because they presented levels of CRP higher than
8 ng/dL, suggesting an acute infection. The study was
performed according to Helsinki Declaration and ap-
proved by the Ethical Committee in Research of the Uni-
versity of São Paulo (203/2011). The individuals had their
identity preserved and participated in the study only after
the Terms of Consent had been signed by their parents or
guardians.
All subjects were examined by the same observer, who
evaluated their weight (measured to the nearest 0.1 kg
on a Filizola adult-type scale with the subject wearing
light clothes, without shoes and with their feet juxta-
posed) and height (measured to the nearest 0.1 cm on a
wall-mounted stadiometer of Halpender–Holtain type
(Tonelli)) [7]. WC was measured in centimeters with an
inelastic tape just above the superior border of the right
iliac crest at the end of normal expiration, according to
the NHANES III study [7]. These methods were chosen
because the original NHANES III included a large sam-
ple of children from different ethnic groups (including
African Americans) that closely resembled our sample.
Systolic blood pressure (SBP) and diastolic blood pres-
sure (DBP) were measured in millimeters of mercury in
the right upper limb with a cuff appropriate to the
length and circumference of the arm, after the child was
rested and had been sitting down for at least five mi-
nutes. Blood pressure (BP) was checked twice during the
appointment and the mean of the two measurements
was used for analysis [8]. Values over 90th percentile
(p90) were considered abnormal [9]. BP z scores were
also calculated based on the reference values for sex, age
and height [9]. BP was checked again at the second ap-
pointment about 45 days after the first evaluation, when
the children returned with the results of the complemen-
tary tests requested. BMI z scores for all children were cal-
culated from the 2007 WHO reference data [10], which
classified them as normal-weight (z score > −1 and < 1) or
overweight/obese (z score ≥ 1).
Laboratory evaluation
At the first clinical evaluation, parents or guardians of
all children were instructed to take their children to the
CRTCA to get their blood drawn after 12-hour over-
night fasting for the measurement of fasting glycemia,
total cholesterol (TC), LDL, TG, HDL, insulin, CRP and
leukocyte count. The assays were run in the Municipal
Hospital of Guarus, in Campos. LDL was calculated
using Friedewald’s formula [11]. Lipid profile values were
established according to the 1st Brazilian Guidelines on
the prevention of atherosclerosis in childhood and adoles-
cence which consider normal levels to be TC < 150 mg/dl,
LDL < 100 mg/dl, TG < 100 mg/dl and HDL ≥ 45 mg/dl
[12]. The cut-off value for the Homeostatic Model of As-
sessment – Insulin Resistance (HOMA-IR) was ≥ 2.5
based on the study of Madeira [13]. Glycemia and lipid
profiles were determined by the colorimetric enzymatic
method using a kit for the Hitachi–Roche modular sys-
tem. Insulin was measured by chemiluminescence using
a Bayer kit, and CRP by immunonephelometry with a
Dade Behring kit (Bayer). Leukocyte count was deter-
mined using an automated data processing system
(Pentra 180 ABX).
Statistical analysis
BP values and metabolic parameters were compared
among groups using Student’s t-test for continuous vari-
ables with a normal distribution and the Mann–Whitney
test for those without a normal distribution. BMI z scores
were calculated according to the 2007 WHO standard
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using Anthro Plus software. The sensitivity and specificity
of BMI z score for the detecting changes in BP or
HOMA-IR were calculated by receiver operating charac-
teristic (ROC) curve analysis. The most sensitive WHtR
cut-off value for the detection of cardio-metabolic changes
was also determined using a ROC curve. Correlation ana-
lysis was conducted using Pearson or Spearman coeffi-
cients; the latter were used when the data were not
normally distributed. Insulin and HOMA-IR values were
not normally distributed on the Kolmogorov–Smirnof test
and it was necessary to transform them into logarithms to
evaluate their correlation with WHtR. Medcalc version
12.1.0.0, GraphPad Instat version 3.00 and Graph Pad
Prism 5 version 5.04 were used for statistical analysis.
Results
Of the 175 children 88 were classified as normal-weight
and 87 as overweight/obese. The mean age with stand-
ard deviation of the two groups was 8.08 ± 1.24 years
and 8.28 ± 1.15 years, respectively. The numbers of girls
and boys were 40/48 and 37/50 for the normal-weight
and the overweight/obese groups, respectively. In
normal-weight group 41/88 were white and 47/88 of Af-
rican American descent; in overweight/obese group 43/
87 were white and 44/87 of African American descent.
Of the 175 children 97 were African American descent
(55%). The demographic and clinical data of children are
shown in Table 1.
There was a significant correlation between BP values
recorded at the first and second appointments (r = 0.95
and r = 0.91 for SBP and DBP, respectively). Mean
WHtR differed significantly between the normal-weight
and overweight/obese groups (0.45 ± 0.004 and 0.58 ±
0.007 respectively, p < 0.0001). There was no difference
between the mean WHtR in girls (n = 77) and that in
boys (n = 86) (0.51 ± 0.009 and 0.52 ± 0.009 respectively;
p = 0.53). There was a significant correlation between
WHtR and BMI z score (r = 0.88, p < 0.0001). As shown
in Table 2 WHtR was significantly correlated with all
cardio-metabolic parameters except glycemia. Among
the inflammatory markers WHtR was correlated with
CRP (r = 0.51, p < 0.0001), but not with leukocyte count
(r = 0.019, p = 0.805).
The sensitivity of WHtR was similar to that of BMI
z score for detecting at least one metabolic change
(HOMA-IR, BP, LDL, HDL or TG): the respective areas
under the curves (AUCs) were 0.739 and 0.717. As shown
in Table 3 there were no differences between the AUCs
for WHtR and BMI with respect to SBP, DBP, HOMA-IR,
LDL and HDL. Neither WHtR nor BMI was able to detect
hypertriglyceridemia. Tables 4 and 5 show the sensitivity
and specificity of WHtR and the 2007 WHO BMI z score
for screening the cardio metabolic alterations with their
respective cut-off values. The most sensitive WHtR cut-
off for HOMA-IR was >0.47, which was also capable of
detecting any one of the cardio-metabolic disturbances
(LDL, HDL, TG or BP) when they were accounted to-
gether. In the normal-weight group 29/88 (33%) had
WHtR > 0.47, whereas in the overweight/obese group the
proportion was 97% (84/87).
Discussion
Obesity in childhood is an important risk factor for the
development of atherosclerotic heart disease [14] once
an increased BMI from 10 years of age is considered the
strongest predictor of premature death by acute myocar-
dial infarction during adult life [15]. Insulin resistance
(IR) seems to have an important role in the pathogen-
esis of atherosclerosis and metabolic syndrome which
are related to overweight and mainly to abdominal adi-
posity [14,16].
BMI is the most traditional anthropometric index used
for diagnosing overweight. As the prevalence of child-
hood obesity has grown up, the WHO reviewed the
2000 Centers for Disease Control (CDC) BMI curves to
increase their sensitivity for the diagnosis of overweight
Table 1 Demographic and clinic data of normal-weight
and overweight/obese 6-10-year-old children from
Campos
Group Normal-weight Overweight/
obese
Statistical
significance
n = 88 n = 87
Girls 40 (45%) 37 (43%) p = 0.8122
White 41 (47%) 43 (49%) p = 0.7630
Age (median ± SD) 8.08 ± 1.24 8.28 ± 1.15 p = 0.2703
WHtR (median ± SD) 0.45 ± 0.004 0.58 ± 0.007 p < 0.0001
Height/age z score −0.31 ± 1.08 0.84 ± 1.17 p < 0.0001
Waist (cm, median ± SD) 56.8 ± 5.22 76.5 ± 10.80 p < 0.0001
BMI z score
(median ± SD)
−0,16 ± 0.64 2.90 ± 0.13 p < 0.0001
SBP z score
(median ± SD)
−0.91 ± 1.12 0.94 ± 0.16 p < 0.0001
DBP z score
(median ± SD)
0.32 ± 0.85 1.71 ± 1.15 p < 0.0001
Table 2 Correlations between WHtR and cardio-metabolic
parameters in normal-weight and overweight/obese
6-10-year-old children from Campos
Metabolic variable r (CI 95%) R2 p value
HOMA-IR 0.83 (0.77 – 0.87) 0.68 < 0.0001
Insulin 0.79 (0.74 – 0.85) 0.64 < 0.0001
LDL 0.25 (0.11– 0.39) 0.06 0.0008
HDL −0.28 (−0.41– 0.13) 0.08 0.0002
TG 0.26 (0.11– 0.39) 0.07 0.0006
Glycemia 0.14 (0.08 – 0.28) 0.02 0.063
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[10], producing the 2007 WHO BMI standard, which is
the most sensitive reference available at present. To our
knowledge this is the first study comparing WHtR to
this BMI reference for the assessment of cardio-
metabolic risk factors, since all others have used the
2000 CDC standard [17,18]. We found WHtR to be cap-
able of detecting an increase in LDL at a cut-off value of
> 0.48 which would not have been possible using the
WHO BMI only, as children with this WHtR are consid-
ered lean using the WHO BMI, because they are classi-
fied in the BMI z score < 0.8. Such findings are in
agreement with those of other population-based studies
that reinforce the importance of including WHtR mea-
surements in routine care, with the aim of detecting the
presence of cardio-metabolic risk factors even in
normal-weight children [6,17,19,20].
We found a strong correlation between WHtR and the
WHO BMI standard with respect to the assessment of
weight (r = 0.88). This finding was close to that reported
by Savva et al. (r = 0.91), who studied adolescents aged
10–14 years [4]. Regarding BP, in the study of Hara et al.
[21] the correlation between WHtR and SBP (r = 0.27)
and DBP (r = 0.25) was lower than that suggested by our
results. Although WHtR was strongly correlated with
HOMA-IR in the present study, this was not the case
for glycemia, probably because IR is incipient in 6–10-
year-old children.
The AUCs for WHtR and BMI in our study were simi-
lar to those observed by Freedman et al. [22] for screen-
ing elevated LDL (0.62 and 0.61 for WHtR and BMI
respectively) and HDL (0.68 and 0.64 respectively). How-
ever, for screening SBP and DBP alterations the WHtR
AUCs found by Freedman were lower than ours (0.68
and 0.54 for SBP and DBP, respectively). We believe that
the differences between our results and those of Freed-
man [22] and Hara [20] regarding BP are a consequence
of a higher proportion of African American descent in
our sample from Rio de Janeiro, when compared to
those from USA and Japan, as hypertension is more
prevalent and severe in this ethnic group and in Latin
American people [23]. The population-based samples
studied by Freedman, for example, comprised 57% of
whites [22] while our sample had 55% of African American
descent.
Both anthropometric indexes were unable to diagnose
hypertriglyceridemia either because IR is still incipient at
this age or due to their ethnicity as people of African
descent have lower serum TG levels [23].
In the present study the correlation with and sensitiv-
ity of WHtR were maximal for IR and hypertension.
This leads us to believe that IR is one of the earliest
metabolic disturbances to arise and contributes to
hypertension, stimulating sodium and water renal reten-
tion, the sympathetic nervous system and vasoconstric-
tion [14]. Through IR the lypolysis is intensified in
adipose tissue, creating atherogenic dyslipidemia which
together with the production of cytokines by visceral
adipose tissue promote inflammatory reactions and hep-
atic CRP synthesis [24,25].
We would like to highlight that until we know this is
the first study to demonstrate a relationship between
WHtR and inflammatory markers. WHtR has previously
been related only to CRP indicating that endothelial in-
flammation may already be evident in 6–10-year-old
children. In contrast to the findings of a study of older
children (8–16 years) [25], the absence of correlation be-
tween WHtR and leukocyte count in our study suggests
Table 3 AUCs for WHtR and 2007 WHO BMI z score for
screening metabolic risk factors in normal-weight and
overweight/obese 6-10-year-old children from Campos
Metabolic
risk
AUC
WHtR p value BMI z score p value
HOMA-IR 0.90 (0.83–0.95)* 0.0001 0.87 (0.81–0.92)* 0.0001
SBP 0.77 (0.70–0.83)* 0.0001 0.80 (0.73–0.87)* 0.0001
DBP 0.80 (0.73–0.85)* 0.0001 0.80 (0.73–0.86)* 0.0001
LDL 0.62 (0.54–0.69)* 0.0062 0.63 (0.55–0.70)* 0.0024
HDL 0.68 (0.61–0.75)* 0.0001 0.67 (0.59–0.74)* 0.0001
TG 0.58 (0.50–0.66)* 0.1002 0.53 (0.46–0.61)* 0.4997
* 95%CI: 95% confidence interval.
Table 4 Sensitivity and specificity of WHtR for screening
metabolic risk factors in normal-weight and overweight/
obese 6–10-year-old children from Campos
Metabolicrisk Sensitivity Specificity WHtR cut-off
(95%CI) (95%CI)
HOMA-IR 92.6 (75.7 – 99) 76.3 (65.2 – 85.3) 0.47
SBP 80.0 (64.4 –91) 68.9 (60.4 – 76.6) 0.51
DBP 76.6 (66 – 85.5) 74.5 (64.7 – 83) 0.49
LDL 65.8 (54 – 76.3) 55.0 (44.2 – 64.6) 0.48
HDL 60.0 (49 – 70.5) 70.0 (59.4 – 79.2) 0.50
TG 66.1 (53 – 77.7) 45.1 (35.8 – 54.8) 0.47
Table 5 Sensitivity and specificity of the 2007 WHO BMI
z score for diagnosing metabolic risk factors in normal-
weight and overweight/obese 6-10-year-old children
from Campos
Metabolic
risk
Sensitivity Specificity BMI
z score(95%CI) (95%CI)
HOMA-IR 88 (68.8 – 97.5) 80.0 (72.7 – 86.1) 2.26
SBP 87.5 (70.2 – 94.3) 68.9 (60.4 – 76.6) 1.39
DBP 79 (68.5 – 87.6) 76.6 (66.9 – 84.5) 1.12
LDL 64.5 (52.7 – 75) 56.6 (46.2 – 66.5) 0.82
HDL 54.1 (43 – 65) 76.7 (67 – 84.9) 1.82
TG 50.0 (37 – 63) 59.3 (49.6 – 68.4) 1.39
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that in 6–10-year-old children this inflammatory process
is mediated by adipokines only.
The International Diabetes Federation (IDF) estab-
lished ethnic and sex-specific cut-off points for WC indi-
cative of metabolic risks in adults [26]. In children under
10 years however, there is no specific cut-off for WC or
BMI that defines abdominal obesity and/or cardio-
metabolic risk [27-29]. This is the reason why WHtR
has become an attractive and practical option in recent
years [30]. The 0.5 cut-off value brings adults and chil-
dren, men and women closer together and allows the
characterization of visceral fat even in normal-weight in-
dividuals [16,18], depending only on a tape measure and
height measurement [5,31]. Some authors have questioned
the use of this cut-off point as a universal indicator of
cardio-metabolic risk [32], arguing that Asian populations
tend to be shorter than Caucasians and as a consequence,
the risk in the former would be increased at a lower WC
[33]. Others, however, did not find any difference between
the sexes, ethnic or age groups [16] because the division
of WC by height aims to minimize such differences [34].
Despite this disagreement cardiovascular risk factors tend
to group together more frequently above 0.5 constituting
the metabolic syndrome [35], as we observed in the
present study. Another advantage of WtHR is the
individualization of the WC cut-off value with respect to
height as an indicator of risk: using a cut-off value of less
than one-half of the individual’s height, shorter adults
could be shown to be at risk without those cut-off points
proposed by the IDF. This value could also be used to
screen for metabolic risk early, even in children under 10.
We would like to highlight some limitations of our
study. The first was that we did not have access to data
on other factors that could influence BP, such as family
history of hypertension, salt intake and the eating habits
of the population under study.
The second limitation was related to the use of the
HOMA-IR for diagnosing IR. Use of the gold standard,
the euglycemic hyperinsulinemic clamp, is not feasible
in children because it is a complex procedure, difficult
to perform and expensive. The HOMA-IR is an alterna-
tive which requires only fasting glucose and insulin mea-
surements [35]. Some authors argue that there is no
consensus regarding the ideal HOMA-IR cut-off value in
children, and the commercially available kits also mea-
sure pro insulin [36]. However, the HOMA-IR is reliable
and practical since it is standardized for a specific popu-
lation as we chose, based on that of Madeira’s study,
whose data came from a cohort of children of similar
age to ours and originating from Rio de Janeiro [12].
Furthermore, results on the HOMA-IR are strongly cor-
related with those obtained using the euglycemic hyper-
insulinemic clamp (r = 0.82) and are thus considered
reliable for epidemiologic studies on a large scale [36].
Regarding the kits used to measure insulin, the cross-
reaction with pro insulin is small (estimated in 8% for
the chemiluminescence test).
Finally we would like to emphasize that our sample
comprised children from low-income families and public
schools in the north of Rio de Janeiro. Therefore, we
suggest caution in the extrapolation of our results. As
the aim is to call attention to the correlation between an
easy anthropometric method (WHtR) for screening the
presence of cardio-metabolic risk factors, we suggest
that further population-based studies should be carried
out for the exploration of the observed associations.
To prevent cardiovascular disease and DM2 increasing
on a large scale the message “keep your waist to less
than half your height” is simple and can be effective in
public health education [37]. It also indicates that each
one of us has an individual critical WC value that can be
more effective in screening for metabolic risk than a sin-
gle cut-off value pre-established for everyone, as has
been proposed recently [37].
Conclusions
WHtR is as sensitive as BMI in screening for cardio-
metabolic and inflammatory risk. It is feasible, has a low
cost and the ability to explain abdominal adiposity and
is able to detect cardio-metabolic risk even in lean chil-
dren. The message “keep your WC to less than half your
height” can be useful for cardio-metabolic risk preven-
tion programs, with the advantage of individualizing WC
cut-point and metabolic risk.
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